MAP2K1 and malignant colon neoplasm: Recently, Peng et al.48 have shown that GIT1 can interact with methionine adenosyltransferase 2B variants and form a scaffold, which recruits and activates MEK1/2 and ERK1/2 to promote cell growth and tumorigenesis in human liver and colon cancer.